Free Trial

Eton Pharmaceuticals (ETON) Insider Trading & Ownership

Eton Pharmaceuticals logo
$10.50 +0.47 (+4.69%)
(As of 11/19/2024 ET)

Eton Pharmaceuticals (NASDAQ:ETON) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
14.89%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$462,673.60
Number Of
Insiders Selling
(Last 12 Months)
0
Get ETON Insider Trade Alerts

Want to know when executives and insiders are buying or selling Eton Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ETON Insider Buying and Selling by Quarter

Eton Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/7/2024Opaleye Management Inc.Major ShareholderBuy11,248$7.22$81,210.56  
10/4/2024Opaleye Management Inc.Major ShareholderBuy16,852$6.77$114,088.04  
9/10/2024Opaleye Management Inc.Major ShareholderBuy57,500$4.65$267,375.00  
(Data available from 1/1/2013 forward)

ETON Insider Trading Activity - Frequently Asked Questions

The list of insiders at Eton Pharmaceuticals includes Opaleye Management Inc., and Sean Brynjelsen. Learn more on insiders at ETON.

14.89% of Eton Pharmaceuticals stock is owned by insiders. Learn more on ETON's insider holdings.

The following insider purchased ETON shares in the last 24 months: Opaleye Management Inc. ($462,673.60).

Insiders have purchased a total of 85,600 ETON shares in the last 24 months for a total of $462,673.60 bought.

Eton Pharmaceuticals Key Executives



This page (NASDAQ:ETON) was last updated on 11/20/2024 by MarketBeat.com Staff
From Our Partners